HQY Healthequity Inc

Price (delayed)

$78.51

Market cap

$6.55B

P/E Ratio

1,308.5

Dividend/share

N/A

EPS

$0.06

Enterprise value

$6.87B

Highlights
HQY's quick ratio has surged by 136% year-on-year and by 115% since the previous quarter
The equity has soared by 78% YoY and by 34% from the previous quarter
The P/E is 139% higher than the 5-year quarterly average of 547.6
HQY's EPS has dropped by 50% since the previous quarter

Key stats

What are the main financial stats of HQY
Market
Shares outstanding
83.39M
Market cap
$6.55B
Enterprise value
$6.87B
Valuations
Price to earnings (P/E)
1,308.5
Price to book (P/B)
3.53
Price to sales (P/S)
8.82
EV/EBIT
271.07
EV/EBITDA
47.2
EV/Sales
9.44
Earnings
Revenue
$727.76M
EBIT
$25.34M
EBITDA
$145.5M
Free cash flow
$134.25M
Per share
EPS
$0.06
Free cash flow per share
$1.64
Book value per share
$22.26
Revenue per share
$8.9
TBVPS
$12.45
Balance sheet
Total assets
$3.16B
Total liabilities
$1.31B
Debt
$1.06B
Equity
$1.85B
Working capital
$672.81M
Liquidity
Debt to equity
0.57
Current ratio
4.5
Quick ratio
4.22
Net debt/EBITDA
2.21
Margins
EBITDA margin
20%
Gross margin
56.4%
Net margin
0.6%
Operating margin
3.2%
Efficiency
Return on assets
0.2%
Return on equity
0.3%
Return on invested capital
2.1%
Return on capital employed
0.9%
Return on sales
3.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HQY stock price

How has the Healthequity stock price performed over time
Intraday
0.68%
1 week
-3.19%
1 month
8.8%
1 year
39.65%
YTD
12.62%
QTD
15.46%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$727.76M
Gross profit
$410.38M
Operating income
$23.2M
Net income
$4.39M
Gross margin
56.4%
Net margin
0.6%
Healthequity's operating margin has plunged by 68% YoY and by 30% from the previous quarter
HQY's operating income has dropped by 64% year-on-year and by 32% since the previous quarter
HQY's net income has dropped by 50% since the previous quarter
The net margin has dropped by 50% since the previous quarter

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
P/E
1,308.5
P/B
3.53
P/S
8.82
EV/EBIT
271.07
EV/EBITDA
47.2
EV/Sales
9.44
The P/E is 139% higher than the 5-year quarterly average of 547.6
HQY's EPS has dropped by 50% since the previous quarter
The equity has soared by 78% YoY and by 34% from the previous quarter
The stock's P/B is 50% below its 5-year quarterly average of 7.1 but 3.8% above its last 4 quarters average of 3.4
The stock's price to sales (P/S) is 28% more than its last 4 quarters average of 6.9 but 28% less than its 5-year quarterly average of 12.2
HQY's revenue is up by 15% year-on-year

Efficiency

How efficient is Healthequity business performance
The ROE has plunged by 57% from the previous quarter
HQY's return on sales is down by 34% since the previous quarter and by 29% year-on-year
The ROA has contracted by 33% from the previous quarter
HQY's ROIC is down by 32% QoQ and by 25% YoY

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 141% higher than its total liabilities
HQY's quick ratio has surged by 136% year-on-year and by 115% since the previous quarter
Healthequity's current ratio has surged by 113% YoY and by 100% QoQ
The debt is 43% smaller than the equity
The equity has soared by 78% YoY and by 34% from the previous quarter
The debt to equity has dropped by 55% year-on-year and by 27% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.